The objective of the MAGBBRIS Project is to enhance ischemic tissue remodelling by encapsulating EPCs-secretome into biocompatible nanocapsules labelled with  magnetic nanoparticles and fluorescent tags, allowing magnetic guidance and retention, simultaneous in vivo imaging and controlled release.

MAGBBRIS is funded within the framework of the EuroNanoMed III Joint Transnational Call
by the following National Founding Agencies:

Euronanomed3 logo

CONSORTIUM PARTNERS

MAGBBRIS is a highly multidisciplinary consortium integrated by 6 partners from 5 European countries, involved in materials-science, biomedical and clinical research and industrial partnership. 

CONTACT US

Email *

Name *

Message

UPCOMING EVENTS

​Teleconference

November 2020

​Teleconference

February 2021

​Teleconference

April 2021